-
Mashup Score: 3
In patients with gastro-oesophageal reflux, the offer of Cytosponge-TFF3 testing results in improved detection of Barrett’s oesophagus. Cytosponge-TFF3 testing could also lead to the diagnosis of treatable dysplasia and early cancer. This strategy will lead to additional endoscopies with some false positive results.
Source: The LancetCategories: Gastroenterology, Latest HeadlinesTweet
New @TheLancet - Cytosponge-trefoil factor 3 versus usual care to identify #Barrett's #oesophagus in a primary care setting (the #BEST3 trial) - https://t.co/QbeyOZAK1g #Barretts #esophagus #oesophagealcancer #esocsm #esophagealcancer @RFitzgerald_lab https://t.co/HdnXJ5ETfp